Thorndale, PA, United States of America

Anthony S Drager

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 3.7

ph-index = 3

Forward Citations = 97(Granted Patents)


Company Filing History:


Years Active: 2013-2021

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Anthony S. Drager

Introduction

Anthony S. Drager, an accomplished inventor based in Thorndale, PA, has made significant contributions to the field of pharmaceuticals, holding a total of nine patents. His innovative work focuses on developing novel prodrugs and formulations that have the potential to improve drug delivery and efficacy.

Latest Patents

Among his latest patents are notable inventions such as those related to “Pharmaceutical prodrugs and methods of their preparation and use.” This patent outlines compounds of Formula (I), where specific variables (X, Y, and Z) are defined. It also describes particles containing these compounds, along with compositions that include a pharmaceutically acceptable carrier. Furthermore, this patent offers methods of treating subjects by administering the described compounds, particles, or compositions. Another significant patent is focused on “Nanoparticulate and macroparticulate formulations,” which details particles created through the polymerization of surfactants and isocyanate-containing compounds, aimed at improved pharmaceutical compositions.

Career Highlights

Throughout his career, Drager has demonstrated a strong commitment to advancing pharmaceutical technology. He has collaborated with leading companies in the industry, including Ignyta, Inc. and Cephalon, Inc., where he has applied his innovative thinking to develop cutting-edge solutions in drug formulation.

Collaborations

Drager has worked alongside distinguished colleagues such as Peter D. Brown and Rachel Y. LaBell, contributing to various projects and research initiatives. These collaborations have enhanced his ability to innovate within the competitive landscape of pharmaceuticals.

Conclusion

Anthony S. Drager exemplifies the spirit of innovation through his dedication to improving pharmaceutical practices. His substantial portfolio of patents not only showcases his inventive capabilities but also signifies his contributions to advancing medical treatment options. With continued exploration in drug formulation and delivery, Drager sets a remarkable example for aspiring inventors in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…